Inactive Instrument
Quotes Charles River Laboratories International, Inc. Xetra
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 202.40 EUR | -6.23% |
|
-10.60% | - |
| Jul. 29 | Align Technology to add directors, launch review after deal with Elliott | RE |
| Jul. 20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |
Performance
| 1 day | -2.40% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
11,301,112,812
Market Cap (USD)
11,301,112,812
Net sales (USD)
4,015,382,000
Number of employees
19,000
Sales / Employee (USD)
211,336
Free-Float
97 %
Free-Float capitalization (EUR)
12,927,998,772
Free-Float capitalization (USD)
11,229,259,733
Indicators
Moving average 5 days
224.4
Moving average 20 days
225.44
Moving average 50 days
216.85
Moving average 100 days
231.37
Price spread / (MMA5)
+10.87%
Price spread / (MMA20)
+11.38%
Price spread / (MMA50)
+7.14%
Price spread / (MMA100)
+14.31%
RSI 9 days
39.09
RSI 14 days
44.71
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -6.23% | -10.60% | - | - | 11.3B | ||
| -0.56% | +3.80% | -0.56% | +12.59% | 49.37B | ||
| -1.99% | +13.09% | +26.59% | +5.15% | 39.14B | ||
| -2.35% | -0.25% | +406.47% | +619.09% | 40.85B | ||
| -3.13% | -3.34% | +4.61% | +47.05% | 35.81B | ||
| +5.56% | +11.70% | +11.64% | +51.50% | 30.5B | ||
| -2.67% | -3.36% | - | - | 16.55B | ||
| -0.90% | -4.54% | +34.38% | +126.76% | 16.14B | ||
| -0.94% | -0.25% | -2.28% | -34.23% | 12.77B | ||
| +0.20% | +3.58% | +2.17% | +9.91% | 13.71B | ||
| Average | -0.89% | +6.06% | +60.38% | +104.72% | 26.62B | |
| Weighted average by Cap. | -0.88% | +7.02% | +78.45% | +130.57% |
Historical Quotes: Charles River Laboratories International, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- CRL Stock
- RV6 Stock
- Quotes Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions
















